📜 SF0056 – A Regulatory Illusion, Not a Ban

Wyoming’s SF0056, signed into law in 2026, is marketed as “consumer protection.” But a close reading shows it’s an industry‑friendly framework that leaves dangerous kratom products on every gas station and vape shop shelf. The bill does not ban kratom. It merely slaps labels and age restrictions on an unregulated opioid while creating the appearance of regulation without solving the core enforcement problem: nobody at the retail level can reliably determine what is actually inside these products in real time.

⛔ Why the Wyoming KCPA is a Deadly Failure

• The 0.2% alkaloid cap is operationally weak. The bill bans products with “drug components concentrated above 0.2%,” aimed at 7‑OH. But there is no field test for 7‑OH at retail. Law enforcement cannot verify compliance during inspections. Determining compliance requires laboratory analysis (LC‑MS/MS or equivalent). Products can be reformulated constantly. The law depends on after‑the‑fact testing rather than real‑time enforcement.
• It assumes labeling equals safety. The bill relies heavily on labeling requirements, warnings, ingredient disclosures, and “consumer protection” language. But labels do not guarantee actual alkaloid content, absence of synthetic adulterants, absence of heavy metals, microbiological safety, or manufacturing consistency. A product can be perfectly labeled and still pharmacologically dangerous or contaminated.
• It creates selective legality for an FDA‑disputed substance. The FDA has repeatedly stated kratom is not lawfully marketed as a dietary supplement and has raised concerns regarding dependence, toxicity, and adulteration. Yet Wyoming’s framework creates a state‑level commercial pathway for products the federal government still considers problematic. Wyoming regulates it like a legitimate consumer commodity while federal authorities continue to question whether it should be sold at all.
• It shifts burden onto underfunded regulators. The bill appropriates money for testing and enforcement, including Department of Agriculture lab functions. But statewide product surveillance is expensive and continuous: thousands of SKUs, reformulated extracts, internet sales, out‑of‑state shipments, smoke shop turnover, and limited personnel. In practice, many KCPA systems end up complaint‑driven rather than proactive.
• It regulates “presentation,” not pharmacology. The bill bans products that resemble candy, appeal to children, or are intended for smoking. Those provisions sound strong politically, but they do little to address high‑potency extracts, dependency potential, poly‑substance use, concentrated alkaloids, or cumulative exposure. The pharmacologic risk remains even if the package is plain brown instead of colorful.
• It may unintentionally legitimize the market. One of the strongest criticisms of KCPA‑style laws is that they can function as a government endorsement signal. Consumers may interpret “regulated” as “safe.” But the underlying toxicology, dependence liability, and contamination concerns remain unresolved. Wyoming considered a full prohibition bill (HB185), but instead adopted a regulated framework after the House softened the Senate’s stronger approach.
• The law still depends on industry honesty. This framework assumes manufacturers submit accurate testing, avoid adulteration, maintain batch consistency, and comply voluntarily. That is difficult in a fragmented market with online sellers, imported materials, extract manufacturers, and rapidly evolving formulations. The law regulates paperwork and percentages more easily than it regulates the actual chemistry reaching consumers.
• Opioid settlement funds are being misused. The bill specifically appropriates opioid settlement money to fund enforcement and implementation. Wyoming is using money obtained because of the opioid crisis – intended for addiction treatment, prevention, recovery, and overdose mitigation – to administer a retail kratom regulatory structure, including testing and oversight of products with opioid‑like pharmacology. That is indefensible.

Bottom line: The Wyoming KCPA is not consumer protection. It is industry protection dressed up in regulatory language. It gives kratom a stamp of approval, makes enforcement impossible, and misuses opioid crisis funds. The only honest answer is repeal and a complete Schedule I ban.

✅ The Only Answer: Repeal the KCPA and Pass a Full Ban

Wyoming should not regulate kratom. It should prohibit it – plain and simple. A full Schedule I ban removes kratom from every gas station, vape shop, and online retailer. No threshold games, no enforcement illusions, no misuse of opioid settlement funds.

If the legislature wants to address kratom, it must do so by ending its sale entirely – not by creating a regulated market that is impossible to enforce and provides false reassurance to the public.

✅ What You Can Do Right Now

• Document retail sales in your community. Take photos of kratom displays in gas stations, vape shops, and stores near schools. These images will help build the case for repeal.
• Build local awareness. Many Wyoming residents don’t know that the KCPA passed – or that it does almost nothing to protect them. Share educational materials with parents, healthcare professionals, educators, local officials, and community groups.
• Recruit stakeholders. Use the list below to connect with health officials, pharmacy boards, law enforcement, and addiction professionals. Ask them to publicly support a full ban and to document the failures of the KCPA.
• Prepare for the next session. Legislative action moves quickly. Build local networks, share educational materials, document retail activity, contact community leaders, and prepare testimony and evidence packets for lawmakers to demand repeal and replacement with a full ban.

Wyoming Organizations & Stakeholders – Build the Coalition for Repeal

Below are key Wyoming groups that can influence future kratom policy. For each category, we explain why they matter and what to ask when you reach out. Use the contact links to start the conversation.

Law Enforcement & Public Safety

Why they matter: No field test means no enforcement. Law enforcement can explain to legislators why the KCPA is impossible to police and why a full ban is the only workable solution.

What to ask: “Will you support a full ban on all kratom products and advocate for repeal of the KCPA? Can you testify that the absence of a field test makes the current law unenforceable?”

Health & Poison Control

Why they matter: The Department of Health and the Poison Center track substance use, poisoning data, and treatment needs. Their data can document the failure of the KCPA and justify a ban.

What to ask: “Will you collect and publish data on kratom-related emergency visits and poisonings under the KCPA? Will you support a full ban?”

Pharmacy

Why they matter: Pharmacists and the Board of Pharmacy have direct knowledge of product safety, contamination risks, and the limitations of self‑regulation. They can advocate for a full ban.

What to ask: “Will your organization issue a public statement supporting a full statewide ban on kratom and calling for repeal of the KCPA? Will you provide data on adverse events or poisoning calls?”

Medical Associations

Why they matter: Physicians, nurses, and addiction specialists see kratom’s harms firsthand. Their public statements carry significant weight with legislators.

What to ask: “Will your organization issue a public statement supporting a full statewide ban on kratom? Will you share data on kratom‑related ER visits or poisonings?”

Addiction Treatment & Recovery Centers

Why they matter: These providers see the real‑world consequences of kratom dependence – withdrawal, failed treatment attempts, and relapse. Their testimony can illustrate the addictive nature of kratom.

What to ask: “Will you support a full ban and provide testimony or written comments about the burden of kratom addiction on your programs?”

Prepare Messages for the Next Session – Repeal and Ban

The KCPA is now law – but it can be repealed. Use the template below to educate legislators about why the KCPA is a failure and why a full ban is necessary.

Call Script for Stakeholder Outreach